Teva (TEVA) Could Recall a Batch of Treanda -WSJ
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Join SI Premium – FREE
Teva (Nasdaq: TEVA) shares have pushed to session lows as WSJ is reporting Teva (Nasdaq: TEVA) may recall a batch of treanda.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aurinia settles patent dispute with Teva over generic voclosporin
- Keenova doses first patient in Phase 3 hammer toe drug trial
- AbbVie lung cancer drug data shows high response rates at WCLC 2026
Create E-mail Alert Related Categories
FDA, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
